Validity and usefulness of a single‐item measure of patient‐reported bother from side effects of cancer therapy

E-ISSN： 1097-0142|124|5|991-997

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.5, 2018-03, pp. : 991-997

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 8, 2015-08 ,pp. : 787-793

John Wiley & Sons Inc

Access to resources Recommend Favorite

The development of a financial toxicity patient‐reported outcome in cancer: The COST measure

CANCER, Vol. 120, Iss. 20, 2014-10 ,pp. : 3245-3253

John Wiley & Sons Inc

Access to resources Recommend Favorite

Choosing a patient-reported outcome measure

By McClimans Leah

Theoretical Medicine, Vol. 32, Iss. 1, 2011-02 ,pp. : 47-60

Springer Publishing Company

Access to resources Recommend Favorite

Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome

Urologia Internationalis, Vol. 86, Iss. 1, 2010-07 ,pp. : 68-72

Karger

Access to resources Recommend Favorite

Development, content validity, and cross‐cultural adaptation of a patient‐reported outcome measure for real‐time symptom assessment in irritable bowel syndrome

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 30, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite